Factors Associated With Early Readmission in Critical Care

Recruiting Observational Study
Early Readmission to the ICU
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Société Française d'Anesthésie et de Réanimation · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The COVID-19 health crisis has highlighted pre-existing challenges in patient flow management within healthcare facilities, especially in critical care units. This has sparked debate regarding the sufficiency of critical care beds in France, while drawing attention to the lack of downstream structures. Inefficient patient flow, leading to bed occupancy bottlenecks, has been correlated with both cr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients over 18 years of age * Hospitalized or admitted to the ICU Exclusion Criteria: * Objection to the use of their data (by patient or a relative when applicable) * Patients under legal protection
Contacts

Merlin DELOURME,, MD

+33 1 42 49 93 94

merlin.delourme@aphp.fr

CONTACT

François DEPRET

+33 1 42 49 93 94

francois.depret@aphp.fr

CONTACT